Stage III Colorectal Cancer Recruiting Phase 1 / 2 Trials for Navitoclax (DB12340)

IndicationStatusPhase
DBCOND0071063 (Stage III Colorectal Cancer)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02079740Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid TumorsTreatment